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Abstract
Mycobacterium cultures, from patients suspected of tuberculosis or nontuberculous mycobacteria (NTM) infection, need to
be identified. It is most critical to identify cultures belonging to the Mycobacterium tuberculosis complex, but also important
to recognize clinically irrelevant or important NTM to allow appropriate patient management. Identification of M.
tuberculosis can be achieved by a simple and cheap lateral flow assay, but identification of other Mycobacterium spp.
generally requires more complex molecular methods. Here we demonstrate that a paramagnetic liquid bead array method
can be used to capture mycobacterial rRNA in crude lysates of positive cultures and use a robust reader to identify the
species in a direct and sensitive manner. We developed an array composed of paramagnetic beads coupled to
oligonucleotides to capture 16 rRNA from eight specific Mycobacterium species and a single secondary biotinilated reporter
probe to allow the captured rRNA to be detected. A ninth less specific bead and its associated reporter probe, designed to
capture 23S rRNA from mycobacteria and related genera, is included as an internal control to confirm the presence of
bacterial rRNA from a GC rich Gram variable genera. Using this rRNA capture assay (rCapA) with the array developed we
were already able to confirm the presence of members of the M. tuberculosis complex and to discriminate a range of NTM
species. This approach is not based on DNA amplification and therefore does not require precautions to avoid amplicon
contamination. Moreover, the new generation of stable and cost effective liquid bead readers provides the necessary
multiplexing potential to develop a robust and highly discriminatory assay.
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Introduction
Automated liquid culture is faster than culture on solid media
and in fact the gold standard in the diagnosis of tuberculosis (TB).
For these reasons liquid culture is widely used to detect and
confirm infection with Mycobacterium tuberculosis. Critically liquid
culture is also more effective at recovering other members of the
Mycobacterium genus [1,2]. These non M. tuberculosis complex
species, the so called non tuberculous mycobacteria (NTM), when
cultured may represent environmental contaminants, colonization
or, particularly in immunosuppressed or aging populations,
represent genuine pathogens [3,4]. Not only in the Western
world, but also in Africa the clinical importance of NTM disease
seems highly underestimated, especially in settings where HIV is
prevalent [5]. This increasing recovery of NTM with modern
culture methods, as well as a likely increase in their importance in
countries with a low burden of tuberculosis and possibly
throughout the world [6], makes Mycobacterium species identifica-
tion from clinical cultures increasingly important. Also, the
treatment for M. tuberculosis complex infection requires at least 6
months and is specifically tailored to this organism. Disease caused
by other (NTM) species requires different drug combinations [3]
and thus it is necessary to confirm the species of mycobacteria
cultured in order to provide appropriate therapy.
Currently, speciation of cultured mycobacterial species is most
effectively achieved by either a simple lateral flow test [7], which in
fact only confirms the presence of a member of the M. tuberculosis
complex. Alternatively, mycobacterial DNA amplification may be
used, followed by a ‘‘macro array’’ hybridization assay, which can
specifically identify a wide range of Mycobacterium species [8].
Although this method combines a high sensitivity and specificity, it
requires an infrastructure for molecular assays and the tests are
expensive and have a turn-around-time of several hours. Another
system available for mycobacterial culture identification is the
Gen-Probe AccuProbe method which uses species specific probes
and a dedicated reader to identify cultures. This method is
effective, but only a single probe can be tested in each assay and if
negative the next most likely target must be tested increasing the
cost of the identification [9]. Therefore, the popularity of this
method is decreasing.
Here we propose an alternative concept with the potential to be
simpler than an DNA amplification/macro array approach, but
like the AccuProbe method not susceptible to the risk of PCR
contamination and associated requirements for amplicon clean
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and exposed rooms, while providing much more information on
species identification than a lateral flow assay [10,11]. To achieve
this, we first inactivate and mechanically lyse an aliquot of a
positive liquid culture in a buffer, which both denatures the
protein present and stabilizes the mycobacterial RNA. This crude
extract is then hybridized, in the RNA stabilizing buffer, to a bead
array of eight paramagnetic xMAP Luminex beads (Liminex
Corp., Texas, USA) coupled to oligonucleotides designed to
capture 16S rRNA from specific Mycobacterium species and a
secondary biotinilated reporter probe. A ninth bead, designed to
non-specifically capture 23S rRNA from mycobacteria and related
genera and its associated reporter probe, is also included as an
internal control to confirm the presence of bacterial rRNA from a
GC rich Gram variable genus. After hybridization the beads and
captured RNA are magnetically concentrated, the lysis buffer is
removed, replaced with analysis buffer and the signal developed.
The processed beads are subsequently analysed using a MAG-
PIXTM (Luminex Corp., Texas, USA) device and the hybridiza-
tion profile used to identify the species present in the culture. The
MAGPIX platform, which unlike previous Luminex readers is
based on a CCD camera and LED illuminated flow cell rather that
a flow cytometer, is a compact robust devise capable of identifying
and quantifying the signal collected on an suspension of up to 50
different bead species. Beads can either be purchased pre coupled
to assay reagents or, as in this report, coupled by the end user to
develop novel assays.
The Mycobacterium genus consists of more than 100 recognized
species. So in order to demonstrate the concept and develop and
optimize protocols presented in this paper we developed a pilot
test bead array to identify nine species. None the less this method
successfully discriminated a useful range of species previously
recovered from patient material and associated with different
clinical significance [3]. This array could be easily extended with
the inclusion of additional beads for other species. In combination
with a newly available, robust reader for bead arrays we feel the
rCapA presented could be particularly suitable for use in
diagnostic mycobacteriology. The general approach of this assay
could be applied in many other applications, such as, the direct
capture of rRNA from other culture samples where speciation is
required [12], rRNA capture from heavily contaminated material




We used a collection of strains available in our laboratory
[11,13,14,15] for developing and testing the methodology
(Table 1). Cultures were grown at 30uC for M. marinum, or 36uC
for other Mycobacterium species to early log phase in 10 mL of
Middlebrook 7H9 liquid media supplemented with OADC.
Subsequently, we tested a series of 14 Mycobacteria Growth
Indicator (MGIT) Tubes (BD NJ, USA), one uninoculated,
cultured at the RIVM that were previously identified using reverse
line blot tests (Hain Lifescience Nehren, Germany) for identifica-
tion, which we used to check the suitability of our method for use
in combination with the MGIT culture system (Table 2). Species
other than mycobacteria were grown in nutrient broth in a shaking
incubator, 200 rpm, overnight at 37uC.
Selection of initial set of probes
The probes selected are listed in Table 3 and the rCapA and
predicted assembly of the probes, in the presence of selected
mycobacterial rRNAs, is illustrated in Figure 1. The species
specific probes tested are based on a variable genomic 16S rRNA
region previously shown to be suitable for mycobacterial
speciation [14]. Specifically, the mycobacterial probe used to
identify the MTB complex in this study is closely related to a
probe, pTub1, previously validated for use in a reverse
hybridization assay [14]. The associated 16S biotin labelled
reporter probe was selected to bind to the rRNA directly 59 of the
capture probe, as this arrangement has been shown to result in the
highest positive signal [10,11].
Probes selected to target mycobacteria of other species were
selected to lie directly 59 of the MTB complex reporter probe
binding to a hyper-variable region of the 16S rRNA (Figure 1).
Table 1. Middlebrook 7H9 cultures used in this study.
Strain Species Source (, reference)
Mtb1A M. tuberculosis RIVM myc5414
B15 M. tuberculosis Resistant mutant of Mtb72,
13
R181 M. tuberculosis Resistant mutant of Mtb72
Mtb72 M. tuberculosis KIT subculture of
ATCC35801
BCG_1 M. bovis KIT sub culture of
ATCC35733
M.afri M. africarnum RIVM myc5544
H15 M. tuberculosis Resistant mutant of Mtb72,
15
H103 M. tuberculosis Resistant mutant of Mtb72,
15
R190 M. tuberculosis Resistant mutant of Mtb72
RB16 M. tuberculosis Resistant mutant of Mtb72
RB19 M. tuberculosis Resistant mutant of Mtb72
M mic1 M. microti KIT collection
M avi1a M. avium KIT collection, 14
M avi15 M. malmoense* KIT collection
M avi30 M. avium RIVM 13528-1071
M avi60 M. avium RIVM 6450-204
M xen6 M. xenopi KIT collection, 14
M abs0278 M. abscessus RIVM 1011100278
M abs2283 M. abscessus RIVM 1011002328
M kan10 M. kansasii KIT collection
M kan20 M. kansasii KIT collection, 14
M scr1 M. scrofulacum KIT collection, 14
M scr2 M. scrofulacum KIT collection
M malm1 M. malmoense KIT collection
M malm2328 M. malmoense RIVM 1011002328
M malm0007 M. malmoense RIVM 1011100007
M gor19 M. gordonae* RIVM C809
Staph Staphylococcus aureus Clinical isolate 3341-7, 11
E. coli Eschericia coli KIT 4069-2
N ast1 Nocadia asteroids* KIT collection isolated from
human sputum
N ast2 Gordonia bronchialis* KIT collection isolated from
human sputum
KIT = Royal Tropical Institute, The Netherlands.
RIVM=Dutch Centre for Infectious Disease Control.
* = Species identification based on sequencing a portion of the 16S rRNA.
doi:10.1371/journal.pone.0032575.t001
rRNA Capture Assay
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This allowed the same reporter probe to be used for all bacterial
species targeted.
In contrast, the 23S capture and reporter probe were selected so
as to bind to a wide range of microorganisms under the
hybridization conditions selected. This probe pair was designed
to act as a positive control, to indicate the presence and
approximate concentration of any rRNA present from the
Mycobacterium or closely related genera.
The liquid bead array was prepared by covalently coupling
each 59 amine modified oligonucleotides to a 5912 carbon spacer
(Table 3) and five thymine residues [16] to 16106 unique
microspheres as described by the manufacturer (carbodiimide
coupling of amine modified oligonucleotides to MagPlexTM-C
magnetic carboxilated xMAPH microspheres, Luminex Corp.).
Once prepared coupled microspheres were re-suspended in 200 ul
of 16TE buffer pH 8 and stored at 4uC in the dark until needed.
These solutions of labeled beads were then combined to produce
bead mixtures (liquid arrays) and suspended in 26SSPE (0.3 M
NaCl, 0.02 M NaH2PO4, 0.002 M EDTA pH 7.4) as required to
a final concentration 45,000 of each bead species per ml. Aliquots
of these mixtures were used in the assay with approximately 1,500
beads of each species used per reaction.
Bacterial killing and lysis
Mycobacterial cultures were heated to 80uC for 30 min prior
to lysis. Bacteria (0.5 ml for Middlebrook culture and 4 ml for
MGIT cultures) were then pelleted by spinning at 10,000 g for
5 min in a micro-centrifuge and the supernatant discarded. The
pelleted cells were then re-suspended, at 1 to 26 original
concentration for Middlebrook cultures and 206 concentration
for MGIT cultures, in 5 M GTC buffer (5 M guanidine
thiocyanate, 0.05 M Tris, 0.02 M EDTA pH 8, 1% triton X-
100). Then to 150 ul aliquots of the concentrated cells 0.2 g of
0.1 mm diameter Zirconium/Silica beads (BioSpec products,
Inc.) was added and the cells mechanically lysed by shaking in a
Retch shaker (Retsch, Du¨sseldorf, Germany) at max speed
(30 Hz) typically for 10 min but up to 60 min to investigate the
effect of increased shaking.
Hybridisation reactions
To 100 ml aliquots of the bacterial lysate prepared above 5 ml of
a 5 mM solution of each labeled detector ologonucleotide and
33 ml of a bead mixture (45,000 of each bead species/ml) was
added. The mixture was then heated to 95uC for 3 min and held
at 50uC with gentle shaking to allow the hybridization to proceed.
For method development hybridization was allowed to continue
overnight, but hybridization kinetics were studied by removing
aliquots of selected samples at 1, 3, 5, and 18 hrs. After
hybridization the samples were placed on a magnetic separator
to concentrate the beads and the supernatant carefully removed.
The beads were then immediately re-suspended in 40 ml of
26SSPE at 50uC and 5 ul of 5 mM of each detector oligonucle-
otide. The beads were then held at 50uC for a further 30 min with
gentle shaking.
Table 2. MGIT cultures used.
Culture ID Identification by GenoType Assay
Mtb 887 M. tuberculosis
Mtb 825 M. tuberculosis
M avi 569 M. avium
M avi 863 M. avium
M xen 346 M. xenopi
M abs 720 M. abscessus
M abs 742 M. abscessus
M kan 793 M. kansasii
M kan 884 M. kansasii
M mal 682 M. malmoense
M mar 674 M. marinum
M gor 587 M. gordonae
M gor 849 M. gordonae
doi:10.1371/journal.pone.0032575.t002




number 59 amine modification GC (%) BASES
16S rRNA
M tuberculosis 27 59-NH2_C12-tttttCTTTCCACCACAAGACATGCATCCCGT 43.8 32
M avium 14 59-NH2_C12-tttttCTTTCCACCAGAAGACATGCGTCTTGA 43.8 32
M gordonae 72 59-NH2_C12-tttttCTTTCCACCACAGGACATGTGTCCTGT 43.8 32
M kansasii 39 59-NH2_C12-tttttCTTTCCACCACAAGGCATGCGCCAAGT 46.9 32
M xenopi 28 59-NH2_C12-tttttCTTTCCACCACCCCACATGCGCAGAAT 46.9 32
M marinum 65 59-NH2_C12-tttttCTTTCCACCACAGGACATGAATCCCGT 43.8 32
M abscessus 34 59-NH2_C12-tttttCTTTGCACCACTCACCATGAAGTGTGT 40.6 32
M malmoense 44 59-NH2_C12-tttttCTTTCCACCCCAAGGCATGCGCCTCGG 56.3 32
23S rRNA - - -
23S+Control 26 59-NH2_C12-tttttCCCTATTCAGACTCGCTTTCGCTGCGGCTA 48.6 35
Detector probes 39 Biotin modification
16S Detector In solution GGTCCTATCCGGTATTAGACCCAGTTTC-39-Biotin 50 28
23S Detector In solution CCCCACCCGGGTTAACCTCGCGACATG-39-Biotin 66.7 27
doi:10.1371/journal.pone.0032575.t003
rRNA Capture Assay
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After this secondary hybridization/wash the beads were
magnetically concentrated on a magnetic separator and washed
twice with 100 ul of 26SSPE at 50uC. The beads were then re-
suspended in 40 ml 16TMAC buffer (5 M tetramethilamonium
chloride, 20% sarkosyl, 1 M Tris HCL pH 8) at 50uC along with
12 ml reporter mix (10 mg/ml streptavidin phycoerythrin conju-
gate in TMAC). Labeling was allowed to continue for 5 min in the
MAGPIX instrument at 50uC then the signals were measured and
the data exported to Excel 2010 (Microsoft, Seattle, USA).
In order to resolve unexpected results we PCR amplified and
cycle sequenced a portion of the 16S rRNA gene which contained




The rCapA designed gave a characteristic profile for members
of the MTB complex which was easily recognized and indepen-
dent of the signal strength; total signals in arbitrary units (AU)
ranged from 827 to 15,047 resulting in a characteristic profile in
each case (Figure 2). During all our experiments the MTB
complex probe invariably gave a signal for the MTBC species
tested that was at least as high as the 23S positive control bead. In
all other species tested the signal from the MTB complex probe
was either absent or dramatically lower (always less than half) the
signal obtained from the 23S positive control (Figure 2). All
members of the MTB complex tested also demonstrated some
cross reaction with the M. marinum probe but this did not result in
misidentification as the M. marinum strain tested gave only a weak
signal with the MTB complex probe (Figure 2).
Effective lysis was essential to obtain good signal and complete
lysis of the MTBC strains tested was not achieved using our lysis
protocol (Figure 3). Reduced hybridisation time also resulted in a
lower signal with 50% of the overnight signal obtained after
between four and six hours (Figure 4).
Background negative control samples and unrelated genera
tested, Staphylococcus aureus and Escherichia coli, gave no detectable
signal with the array. We also tested two mycolic acid containing,
GC rich bacteria, identified based on partial 16S rRNA sequence
as Nocadia asteroides and Gordonia bronchialis, which were originally
obtained from sputum culture. These strains gave no detectable
signal with the 16S rRNA probes, but yielded a clear signal with
the 23S positive control bead (Figure 2).
One culture initially identified as M. avium (M. avium 15) gave a
signal with the M. malmoense beads and the 23S positive control but
no signal with the other beads including the M. avium probe.
Because of this unexplained result we amplified and sequenced the
respective part of the 16S rRNA of this strain and confirmed it had
been misidentified in our collection [17]. Thus the M. avium, M.
xenopi, M. abscessus, M. kansasii, and M. marinum probes exclusively
reacted with members of their respective species (Figure 2). The
M. kansasii probe also reacted with the two M. scrofulaceum isolates
tested (Mscr1 and Mscr2, Figure 2). The M. gordonae probe we
selected was unfortunately not functional (Figure 2).
Discussion
The recent availability of a robust and relatively cost effective
reader for a 50 plex liquid bead array (Luminex MAGPIX)
stimulated us to explore the possibility of using this system to
identify Mycobacterium cultures based on a method previously
applied to the identification of other species [10] and mRNA
expression analysis in Staphylococci [11].We developed an eight
bead array to capture and discriminate 16S rRNA from members
of the Mycobacterium genus and a ninth bead to nonspecifically
capture 23S rRNA from mycobacteria and related genera to act as
a positive control for the presence of GC rich gram variable
organisms.
The samples from MGIT cultures tested gave higher signals
(Figure 2, lower section), in part presumably as these samples were
more highly concentrated during processing (see methods) but also
possibly due to the more rapid growth of the mycobacteria in this
medium and associated increase in rRNA expression. As we did
not have access to automated culture in our laboratory, these
samples were not tested directly but transported to our laboratory
after they were flagged as positive by the machine. Future work
should include testing in a more realistic ‘‘diagnostic setting’’.
Our current rCapA is functional and reveals that in principle
this is a highly efficient and robust approach for the identification
Figure 1. Schematic alignment of the bead array and target rRNA assembly.
doi:10.1371/journal.pone.0032575.g001
rRNA Capture Assay
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Figure 2. Results of hybridiations of, 31 Middlebrook cultures, 13 MGIT cultures, and 4 controls, to the 9 bead array. Fluorescence
intensity in arbitrary units is indicated on the left hand side as determined by the MAGPIX machine, this data is visualized in the form of a ‘‘line probe
assay’’ (Excel 2010, Microsoft, Seattle, USA) on the right hand side where the % of the total signal in each assay resulting from each specific bead is
indicated as a grey scale (where ,10% of total signal from a bead species is white, and .30% of total signal from a bead species is black).
doi:10.1371/journal.pone.0032575.g002
Figure 3. Effect of increasing lysis time on the yield of rRNA from an NTM (M. avium) and anM. tuberculosis culture. Solid lines and filled
triangles/diamonds indicate the species specific bead signal, dashed lines and filled squares represent the 23S rRNA control signal, empty triangles
indicate the average signal from the beads targeting other species (error bars +2 one standard deviation). Lysis was performed at 30 Hz in the
presence of Zirconium beads for pulses of 10 minutes. Aliquots of the prepared mycobacteria were removed after each period of shaking collected
and analysed together in the rRNA capture MAGPIX assay. Upper graph M. avium lower graph M. tuberculosis.
doi:10.1371/journal.pone.0032575.g003
rRNA Capture Assay
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of mycobacteria. However, there is still considerable potential left
to improve the performance of the assay. Most striking are the
experiments on the effect of lysis time on the signal obtained. For
the experiments reported in Figure 3, lysis by shaking was allowed
to continue for 10 min at 30 Hz. Increasing the shaking time for a
M. avium culture demonstrated lysis of this species was almost
complete after 10 min (Figure 3, upper graph) and optimal lysis
was achieved after approximately 20 min of shaking (2610 min
with a 5 min pause). Further shaking did not result in an increase
in the signal but, importantly, also no decrease in signal. Thus,
there is no evidence that prolonged shaking resulted in damage or
loss of rRNA (Figure 3A). In contrast for an M. tuberculosis culture
prolonged shaking resulted in a steady almost linear increase in the
signal obtained (Figure 3, lower graph). This indicates that the lysis
achieved for MTB complex cultures with our current protocol was
incomplete and a more efficient lysis system would result in
increased signal/sensitivity. Alternative lysis methods should be
explored; other workers have for instance developed simple
disposable lysis chambers [18,19] which would appear to be ideal
for this type of assay.
We typically allowed hybridizations to continue overnight and
analysed the results the next morning. It was also possible to
perform the assay in one day, with a 4–5 hour hybridization step
(Figure 4). Under these conditions approximately 60% of the
overnight signal was obtained. The total signal obtained did not
alter the interpretation of profiles obtained. For example, the first
and second samples in Figure 2, M. tuberculosis Mtb1A and M.
tuberculosis Mtb1B were hybridized for 4 hrs and 18 hrs, respec-
tively.
A rule based and/or an automated species identification system
is desirable and from these results appears realistic but a larger
number of samples would need to be tested to develop and validate
such an algorithm.
The M. kansasii probe also reacted with the two M. scrofulaceum
isolates tested (Mscr1 and Mscr2, Figure 2), this was the result of
an identical 16S rRNA sequence for the region targeted by the
probe selected for this species. In order to discriminate these
species a second region of the rRNA would need to be targeted.
The M. gordonae probe we selected was unfortunately not functional
(Figure 2) and 15 M. gordonae cultures tested all reacted only with
the 23S positive control (results not shown). Thus, in common with
most molecular assays not all probes designed in silico function in
this assay even if the sequence is correct and probes must be
experimentally screened for functionality.
Bacterial speciation is required when liquid culture is performed
for tuberculosis diagnostics [2]. The rCapA presented here is
particularly appealing for this purpose as unlike other ‘‘macro
array’’ methods widely used in tuberculosis diagnostics [20] there
is no need for a nucleic acid amplification/labelling step and
associated need for stringent amplicon contamination controls.
Combined with the recently developed robust liquid array readers
we believe an expanded version of our array could considerably
simplify the speciation of positive Mycobacterial cultures.
As a next step, extension and optimization of the panel of
beads/probes and testing the performance on a larger collection of
Mycobacterium isolates associated with disease and colonization or
contamination should be undertaken. The analysis system used in
this study is in principle capable of detecting 50 unique bead
species although systems with even higher multiplexing capacity
are available [21]. Our experiments also demonstrated that further
optimization of the protocol can certainly streamline and increase
the sensitivity of the rCapA. We regard it as unlikely that the
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sensitivity could be increased sufficiently to reliably directly detect
Mycobacterium species from clinical material using the bead array
detection system, although, other detection methods are being
developed and it is not totally inconceivable that the rapid
developments in DNA and nano technology relating to detection
and signal amplification may ultimately be able to achieve direct
identification of bacteria in clinical material using this approach.
These developments in molecular detection [22,23] deserve
serious consideration by the microbial diagnostics community as
and when they are reported.
The use of an amplification free system is potentially very robust
utilizing mainly stable chemical reagents and is intrinsically
resistant to amplicon contamination problems that have compli-
cated the provision of amplification assays for infectious disease
diagnostics where they are most needed. Finally, even moderate
increases in sensitivity would allow RNA species other than the
very highly expressed rRNA to be targeted e.g. highly expressed
mRNA species such as rpoB mRNA [11,24] and thereby greatly
extend the application of the rCapA by providing the potential to
discriminate more closely related genetic clades, with identical 16S
rRNA sequences and detect additional characteristics such as drug
resistance.
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